CYTOSORBENTS CORPORATION Preferred Stock, Value, Issued
CYTOSORBENTS CORPORATION (CTSO) had Preferred Stock, Value, Issued of $0 as of 2021-12-31, per its 10-K filed 2022-03-10.
Discontinued › Balance Sheet › Equity, Attributable to Parent
us-gaap:PreferredStockValue · last filed 2022-03-10
- 2021-12-31: Preferred Stock, Value, Issued $0.00.
- 2020-12-31: Preferred Stock, Value, Issued $0.00.
- 2020-09-30: Preferred Stock, Value, Issued $0.00.
- 2020-06-30: Preferred Stock, Value, Issued $0.00.
| Period end | Preferred Stock, Value, Issued |
|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-03-10 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-10 |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-04 |
| 2020-06-30 | $0.00 10-Q · filed 2020-08-04 |
| 2020-03-31 | $0.00 10-Q · filed 2020-05-05 |
| 2019-12-31 | $0.00 10-K · filed 2021-03-09 |
| 2019-09-30 | $0.00 10-Q · filed 2019-11-05 |
| 2019-06-30 | $0.00 10-Q · filed 2019-08-06 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-07 |
| 2018-12-31 | $0.00 10-Q · filed 2019-11-05 |
| 2018-09-30 | $0.00 10-Q · filed 2018-11-06 |
| 2018-06-30 | $0.00 10-Q · filed 2018-08-02 |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-08 |
| 2017-12-31 | $0.00 10-Q · filed 2018-11-06 |
| 2017-09-30 | $0.00 10-Q · filed 2017-11-09 |
| 2017-06-30 | $0.00 10-Q · filed 2017-08-07 |
| 2017-03-31 | $0.00 10-Q · filed 2017-05-08 |
| 2016-12-31 | $0.00 10-Q · filed 2017-11-09 |
| 2016-09-30 | $0.00 10-Q · filed 2016-11-07 |
| 2016-06-30 | $0.00 10-Q · filed 2016-08-09 |
| 2016-03-31 | $0.00 10-Q · filed 2016-05-09 |
| 2015-12-31 | $0.00 10-Q · filed 2016-11-07 |
| 2014-09-30 | $1.90K 10-Q · filed 2014-11-12 |
| 2014-06-30 | $1.85K 10-Q · filed 2014-08-12 |
| 2014-03-31 | $1.80K 10-Q · filed 2014-05-14 |
| 2013-12-31 | $1.76K 10-Q · filed 2014-11-12 |
| 2013-09-30 | $1.72K 10-Q · filed 2013-11-06 |
| 2013-06-30 | $1.68K 10-Q · filed 2013-08-14 |
| 2013-03-31 | $1.63K 10-Q · filed 2013-05-15 |
| 2012-12-31 | $1.59K 10-K · filed 2014-03-31 |
| 2011-12-31 | $1.45K 10-K · filed 2013-04-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |